Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
AllianceBernstein
AB
$3.42B
| $2.54M | 0.01% |
98,200
-59,499
| -38% | -$1.49M |
|
|
GES
1602
DELISTED
Guess Inc
GES
| $2.54M | 0.01% |
94,000
-100,100
| -52% | -$2.71M |
|
1603
United Microelectronic
UMC
$47.7B
| $2.54M | 0.01% |
1,052,500
+975,800
| +1,272% | +$2.18M |
|
|
INFI
1604
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.53M | 0.01% |
198,600
-299,940
| -60% | -$3.12M |
|
1605
Acadia Healthcare
ACHC
$2.84B
| $2.52M | 0.01% |
55,300
-46,782
| -46% | -$2.06M |
|
1606
UFP Industries
UFPI
$4.97B
| $2.52M | 0.01% |
156,372
-62,634
| -29% | -$1.06M |
|
1607
Consumer Portfolio Services
CPSS
$206M
| $2.51M | 0.01% |
328,962
+87,301
| +36% | +$643K |
|
1608
Eldorado Gold
EGO
$10.3B
| $2.51M | 0.01% |
+65,520
| New | +$2.01M |
|
1609
Mueller Industries
MLI
$14.6B
| $2.5M | 0.01% |
+340,000
| New | +$2.47M |
|
|
NBG
1610
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
| $2.5M | 0.01% |
678,966
-1,098,884
| -62% | -$4.4M |
|
1611
Espey Mfg & Electronics Corp
ESP
$193M
| $2.49M | 0.01% |
99,200
+4,600
| +5% | +$120K |
|
|
BDSI
1612
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.49M | 0.01% |
+206,462
| New | +$1.96M |
|
|
ANAT
1613
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2.49M | 0.01% |
21,800
+5,486
| +34% | +$623K |
|
|
CCEC
1614
Capital Clean Energy Carriers
CCEC
$1.37B
| $2.48M | 0.01% |
+30,973
| New | +$2.35M |
|
1615
Ardmore Shipping
ASC
$722M
| $2.47M | 0.01% |
178,600
+165,016
| +1,215% | +$2.23M |
|
1616
CBIZ
CBZ
$2.96B
| $2.47M | 0.01% |
273,557
-9,379
| -3% | -$81.7K |
|
|
KSPN
1617
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $2.46M | 0.01% |
32,361
+3,605
| +13% | +$247K |
|
|
AVEO
1618
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.46M | 0.01% |
134,349
+6,804
| +5% | +$88.5K |
|
|
SP
1619
DELISTED
SP Plus Corporation
SP
| $2.46M | 0.01% |
114,864
+46,564
| +68% | +$1.08M |
|
|
AEGR
1620
DELISTED
Aegerion Pharmaceuticals
AEGR
| $2.46M | 0.01% |
+76,500
| New | +$2.85M |
|
1621
Sypris Solutions
SYPR
$49M
| $2.45M | 0.01% |
439,400
+30,400
| +7% | +$125K |
|
|
VTG
1622
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
| $2.45M | 0.01% |
+1,276,300
| New | +$2.21M |
|
1623
Canadian Pacific Kansas City
CP
$82.4B
| $2.45M | 0.01% |
67,500
-1,244,180
| -95% | -$40.8M |
|
|
IPAS
1624
DELISTED
Ipass Inc Common Stock
IPAS
| $2.44M | 0.01% |
203,720
+6,880
| +3% | +$96.8K |
|
|
ABMD
1625
DELISTED
Abiomed Inc
ABMD
| $2.44M | 0.01% |
+97,223
| New | +$2.26M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.